Management of Allopurinol 300 mg and Losartan 100 mg
Continue both medications as this is an excellent combination for a patient with gout and hypertension, as losartan provides modest additional uric acid lowering (approximately 0.3 mg/dL) while treating blood pressure. 1, 2, 3
Current Regimen Assessment
Your patient is on appropriate doses for both conditions:
- Allopurinol 300 mg daily is a standard maintenance dose for gout 2
- Losartan 100 mg daily is the maximum dose for hypertension and provides optimal uricosuric effect 4, 3
Key Management Points
Verify Allopurinol Initiation Was Done Correctly
The 2020 ACR guidelines strongly recommend starting allopurinol at ≤100 mg/day with gradual titration 1. If this patient was started directly at 300 mg without titration, this increases flare risk, but since they're already on this dose, continue it if tolerated.
Ensure Anti-inflammatory Prophylaxis
The patient must be on prophylaxis (colchicine, NSAIDs, or prednisone) for 3-6 months when initiating or adjusting urate-lowering therapy 1, 2. The ACR strongly recommends this to prevent gout flares. Continue prophylaxis until:
- Serum uric acid is normalized (<6 mg/dL)
- Patient has been flare-free for several months 2
Monitor Serum Uric Acid
Target serum uric acid <6 mg/dL (or <5 mg/dL for severe tophaceous gout) 1, 2. Check levels periodically to determine if allopurinol dose needs adjustment:
- If above target: Can increase allopurinol by 100 mg increments weekly up to 800 mg/day maximum 2
- Losartan provides an additional ~0.3 mg/dL reduction, which is modest but clinically meaningful 3, 5
Assess Renal Function
Critical consideration: Both drugs require dose adjustment in chronic kidney disease 1, 2:
- If CrCl 10-20 mL/min: Reduce allopurinol to 200 mg daily
- If CrCl <10 mL/min: Reduce allopurinol to 100 mg daily
- Losartan is safe in CKD and remains the preferred ARB for gout patients 6
Optimize the Synergy
The combination is particularly advantageous because:
- Losartan is the only ARB with significant uricosuric properties 6, 7
- It increases urinary excretion of uric acid, xanthine, and oxypurinol by 2-4 fold 4
- This partially counteracts diuretic-induced hyperuricemia if patient is on thiazides 5
Important caveat: While losartan lowers uric acid modestly (~50 µmol/L or 0.3 mg/dL), it is not sufficient as monotherapy for gout 8, 5. The allopurinol remains the primary urate-lowering agent per ACR guidelines 1.
Ensure Adequate Hydration
Maintain daily urinary output of at least 2 liters to prevent xanthine calculi formation and urate precipitation 2. This is particularly important with the uricosuric effect of losartan 4.
Common Pitfall to Avoid
Do not switch from losartan to another ARB (like irbesartan) in gout patients, as other ARBs lack the uricosuric effect 7. Losartan should be the preferred antihypertensive in this population 6, 9.